http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Realbotix Reports Financial Results for Q2-2025
-
Auxly Reports 2025 First Quarter Results
-
Skyharbour and JV Partner Orano to Commence Extensive Summer 2025 Drilling Program at Preston Uranium Project
-
Kobo Resources Reports Strong Gold Intercepts of 8.0 m at 2.07 g/t Au and 8.0 m at 2.16 g/t Au and Improves Structural Understanding at Kossou
-
Valour partners with GulfCap Investment Bank for Cross-Listing its Exchange Traded Products on the Nairobi Securities Exchange
-
The Fresh Factory Reports Record Billed Revenue & EBITDA in Q1 2025
-
Echo Launches Worldwide and Starts Exclusive Public Sale for the ECHO Token
-
Crypto Influencer Crypto Costa Joins BYDFi as Global Brand Ambassador
-
Walmart reports revenue of 2.5%, up 4.0% in constant currency (cc) with operating income growing of 4.3%, or 3.0% adjusted (cc)
-
QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025
-
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
-
West Point Gold Announces Additional Drill Results from Gold Chain Project, Arizona
-
Annual Report and Notice of Meeting
-
Bragg Gaming Group Reports 7.1% First Quarter 2025 Revenue Rise to EUR 25.5 Million (USD 28.6 Million); 27%¹ Revenue Growth Achieved Excluding the Netherlands
-
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2025
-
Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion
-
Exploration Program for the Flagship Pine Ridge Uranium Project In Wyoming's Prolific Powder River Basin
-
Merck (MRK) Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival
-
Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All C
-
CoinEx Charity Leverages Starlink to Connect Adjarra University Center, Advancing Its “Bridge to Hope” Mission
-
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
-
Liquibase Partners With Databricks to Bring Modern Change Management to the Lakehouse
-
JCPenney Welcomes PROUDLY’s Baby Apparel Collection from Power Couple Gabrielle Union and Dwyane Wade
-
Tradoor Unveils ‘Fastest DEX on TON’ Following $3.2m in Financing
-
IUX MARKETS LTD WINS BIG AT GLOBAL BRAND AWARDS 2025
-
AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON
-
Genflow Biosciences PLC Announces Key SIRT6 Patent Application
-
Mesoblast Limited (MSB) received seven years of orphan-drug exclusive approval from US FDA
-
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
-
UNH CLASS ACTION UPDATE: Rosen Law Firm Expands Class Period to Include More UnitedHealth Group Incorporated Investors in Securities Class Action First Filed by the Firm- UNH
-
ROSEN, A LEADING LAW FIRM, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CODI
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages SoundHound AI, Inc. Investors to Secure Counsel Before Important May 27 Deadline in Securities Class Action - SOUN, SOUNW
-
ROSEN, A LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI
-
ROSEN, A LEADING LAW FIRM, Encourages Ultra Clean Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UCTT
-
Frontera Announces the Closing and Funding of The Recapitalization of Its ODL Interest Through a New $220 Million Non-Recourse, Secured Loan
-
ROSEN, A TOP-RANKED INVESTOR RIGHTS FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO
-
ROSEN, A LEADING LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NSSC
-
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Solaris Energy Infrastructure, Inc. Investors to Secure Counsel Before Important May 27 Deadline in Securities Class Action - SEI
-
ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
PPTA DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Perpetua Resources Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 20 Deadline in Securities Class Act
-
TBBK DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important May 16 Deadline in Securities Class Action - TBBK
-
ROSEN, A LEADING LAW FIRM, Encourages XP Inc. Investors to Inquire About Securities Class Action Investigation - XP
-
ROSEN, A LEADING LAW FIRM, Encourages Ibotta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBTA
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BITF
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBAI
-
Merck (MRK) announces FDA approval of WELIREG
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

